The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Billiau, A.
Right arrow Articles by Carton, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Billiau, A.
Right arrow Articles by Carton, H.

The Journal of Immunology, Vol 140, Issue 5 1506-1510, Copyright © 1988 by American Association of Immunologists

ARTICLES

Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma

A Billiau, H Heremans, F Vandekerckhove, R Dijkmans, H Sobis, E Meulepas and H Carton
Rega Institute for Medical Microbiology, University of Leuven, Belgium.

Acute experimental allergic encephalomyelitis (EAE) was induced in C57BL/6J and SJL/J mice by injection of isologous spinal cord homogenate given in conjunction with Bordetella pertussis and Freund's adjuvant. SJL/J mice showed a highly aggressive and 100% lethal form of the disease; C57BL/6J mice were much less susceptible as they had low morbidity rates (20 to 40%), low disease scores, and mostly no mortality. Treatment of these low susceptibility mice with neutralizing mAb against IFN-gamma caused an increase in morbidity rates as well as significant mortality (up to 80%). Similar antibody treatment did not affect the course of the disease in the high susceptibility SJL/J mice. However, treatment of these mice with IFN-gamma resulted in reduced morbidity and mortality. A similar but less pronounced inhibition of the disease in SJL/J mice could be obtained by administration of IFN- alpha/beta or by acute infection with lactate dehydrogenase virus. The results indicate that endogenous as well as exogenous IFN can exert a down-regulating effect on the development of EAE. They also indicate that endogenous IFN-gamma is produced during the development of EAE and plays a disease-limiting role.


This article has been cited by other articles:


Home page
 GutHome page
T Kobayashi, S Okamoto, T Hisamatsu, N Kamada, H Chinen, R Saito, M T Kitazume, A Nakazawa, A Sugita, K Koganei, et al.
IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease
Gut, December 1, 2008; 57(12): 1682 - 1689.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Lee, E. K. Reinke, A. L. Zozulya, M. Sandor, and Z. Fabry
Mycobacterium bovis Bacille Calmette-Guerin Infection in the CNS Suppresses Experimental Autoimmune Encephalomyelitis and Th17 Responses in an IFN-{gamma}-Independent Manner
J. Immunol., November 1, 2008; 181(9): 6201 - 6212.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Ochoa-Reparaz, A. Rynda, M. A. Ascon, X. Yang, I. Kochetkova, C. Riccardi, G. Callis, T. Trunkle, and D. W. Pascual
IL-13 Production by Regulatory T Cells Protects against Experimental Autoimmune Encephalomyelitis Independently of Autoantigen
J. Immunol., July 15, 2008; 181(2): 954 - 968.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
L. Steinman
A rush to judgment on Th17
J. Exp. Med., July 7, 2008; 205(7): 1517 - 1522.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Zhang, G. Xu, L. Zhang, A. I. Roberts, and Y. Shi
Th17 Cells Undergo Fas-Mediated Activation-Induced Cell Death Independent of IFN-{gamma}
J. Immunol., July 1, 2008; 181(1): 190 - 196.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Mangalam, D. Luckey, E. Basal, M. Behrens, M. Rodriguez, and C. David
HLA-DQ6 (DQB1*0601)-Restricted T Cells Protect against Experimental Autoimmune Encephalomyelitis in HLA-DR3.DQ6 Double-Transgenic Mice by Generating Anti-Inflammatory IFN-{gamma}
J. Immunol., June 1, 2008; 180(11): 7747 - 7756.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. G. Brem-Exner, C. Sattler, J. A. Hutchinson, G. E. Koehl, K. Kronenberg, S. Farkas, S. Inoue, C. Blank, S. J. Knechtle, H. J. Schlitt, et al.
Macrophages Driven to a Novel State of Activation Have Anti-Inflammatory Properties in Mice
J. Immunol., January 1, 2008; 180(1): 335 - 349.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Millward, M. Caruso, I. L. Campbell, J. Gauldie, and T. Owens
IFN-{gamma}-Induced Chemokines Synergize with Pertussis Toxin to Promote T Cell Entry to the Central Nervous System
J. Immunol., June 15, 2007; 178(12): 8175 - 8182.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
H. Kelchtermans, S. Struyf, B. De Klerck, T. Mitera, M. Alen, L. Geboes, M. Van Balen, C. Dillen, W. Put, C. Gysemans, et al.
Protective role of IFN-{gamma} in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production
J. Leukoc. Biol., April 1, 2007; 81(4): 1044 - 1053.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. H. Hofstetter, K. V. Toyka, M. Tary-Lehmann, and P. V. Lehmann
Kinetics and Organ Distribution of IL-17-Producing CD4 Cells in Proteolipid Protein 139-151 Peptide-Induced Experimental Autoimmune Encephalomyelitis of SJL Mice
J. Immunol., February 1, 2007; 178(3): 1372 - 1378.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Minguela, S. Pastor, W. Mi, J. A. Richardson, and E. S. Ward
Feedback Regulation of Murine Autoimmunity via Dominant Anti-Inflammatory Effects of Interferon {gamma}
J. Immunol., January 1, 2007; 178(1): 134 - 144.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Toichi, G. Torres, T. S. McCormick, T. Chang, M. A. Mascelli, C. L. Kauffman, N. Aria, A. B. Gottlieb, D. E. Everitt, B. Frederick, et al.
An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12/IL-23 in Psoriasis
J. Immunol., October 1, 2006; 177(7): 4917 - 4926.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y.-N. Zhu, X.-G. Zhong, J.-Q. Feng, Y.-F. Yang, Y.-F. Fu, J. Ni, Q.-F. Liu, W. Tang, W.-M. Zhao, and J.-P. Zuo
Periplocoside E Inhibits Experimental Allergic Encephalomyelitis by Suppressing Interleukin 12-Dependent CCR5 Expression and Interferon-{gamma}-Dependent CXCR3 Expression in T Lymphocytes
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1153 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Horiuchi, A. Itoh, D. Pleasure, and T. Itoh
MEK-ERK Signaling Is Involved in Interferon-{gamma}-induced Death of Oligodendroglial Progenitor Cells
J. Biol. Chem., July 21, 2006; 281(29): 20095 - 20106.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. Tsunoda, J. E. Libbey, L.-Q. Kuang, E. J. Terry, and R. S. Fujinami
Massive Apoptosis in Lymphoid Organs in Animal Models for Primary and Secondary Progressive Multiple Sclerosis
Am. J. Pathol., December 1, 2005; 167(6): 1631 - 1646.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
R. J. Boyton, S. Davies, C. Marden, C. Fantino, C. Reynolds, K. Portugal, H. Dewchand, and D. M. Altmann
Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread
Int. Immunol., September 1, 2005; 17(9): 1157 - 1165.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. P. Olcott, J. Tian, V. Walker, H. Dang, B. Middleton, L. Adorini, L. Washburn, and D. L. Kaufman
Antigen-Based Therapies Using Ignored Determinants of {beta} Cell Antigens Can More Effectively Inhibit Late-Stage Autoimmune Disease in Diabetes-Prone Mice
J. Immunol., August 1, 2005; 175(3): 1991 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
B. Sawitzki, C. I. Kingsley, V. Oliveira, M. Karim, M. Herber, and K. J. Wood
IFN-{gamma} production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo
J. Exp. Med., June 20, 2005; 201(12): 1925 - 1935.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. J. Mekala, R. S. Alli, and T. L. Geiger
IL-10-Dependent Suppression of Experimental Allergic Encephalomyelitis by Th2-Differentiated, Anti-TCR Redirected T Lymphocytes
J. Immunol., March 15, 2005; 174(6): 3789 - 3797.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume
Interferon-{gamma}: an overview of signals, mechanisms and functions
J. Leukoc. Biol., February 1, 2004; 75(2): 163 - 189.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. G. Barin, M. Afanasyeva, M. V. Talor, N. R. Rose, C. L. Burek, and P. Caturegli
Thyroid-Specific Expression of IFN-{gamma} Limits Experimental Autoimmune Thyroiditis by Suppressing Lymphocyte Activation in Cervical Lymph Nodes
J. Immunol., June 1, 2003; 170(11): 5523 - 5529.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. M. Liva and R. R. Voskuhl
Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production
J. Immunol., August 15, 2001; 167(4): 2060 - 2067.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Furlan, E. Brambilla, F. Ruffini, P. L. Poliani, A. Bergami, P. C. Marconi, D. M. Franciotta, G. Penna, G. Comi, L. Adorini, et al.
Intrathecal Delivery of IFN-{gamma} Protects C57BL/6 Mice from Chronic-Progressive Experimental Autoimmune Encephalomyelitis by Increasing Apoptosis of Central Nervous System-Infiltrating Lymphocytes
J. Immunol., August 1, 2001; 167(3): 1821 - 1829.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. L. Meyer, J. Benson, F. Song, N. Javed, I. E. Gienapp, J. Goverman, T. A. Brabb, L. Hood, and C. C. Whitacre
Rapid Depletion of Peripheral Antigen-Specific T Cells in TCR-Transgenic Mice After Oral Administration of Myelin Basic Protein
J. Immunol., May 1, 2001; 166(9): 5773 - 5781.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
P. Matthys, K. Vermeire, H. Heremans, and A. Billiau
The protective effect of IFN-{gamma} in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis
J. Leukoc. Biol., October 1, 2000; 68(4): 447 - 454.
[Abstract] [Full Text]

Home page
 Int ImmunolHome page
J.-B. Sun, B.-G. Xiao, M. Lindblad, B.-L. Li, H. Link, C. Czerkinsky, and J. Holmgren
Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-{beta}-secreting cells and suppressing chemokine expression
Int. Immunol., October 1, 2000; 12(10): 1449 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Pelfrey, R. A. Rudick, A. C. Cotleur, J.-C. Lee, M. Tary-Lehmann, and P. V. Lehmann
Quantification of Self-Recognition in Multiple Sclerosis by Single-Cell Analysis of Cytokine Production
J. Immunol., August 1, 2000; 165(3): 1641 - 1651.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Matthys, K. Vermeire, T. Mitera, H. Heremans, S. Huang, D. Schols, C. De Wolf-Peeters, and A. Billiau
Enhanced Autoimmune Arthritis in IFN-{gamma} Receptor-Deficient Mice Is Conditioned by Mycobacteria in Freund's Adjuvant and by Increased Expansion of Mac-1+ Myeloid Cells
J. Immunol., September 15, 1999; 163(6): 3503 - 3510.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. T. Chang, C. Jabs, R. A. Sobel, V. K. Kuchroo, and A. H. Sharpe
Studies in B7-deficient Mice Reveal a Critical Role for B7 Costimulation in Both Induction and Effector Phases of Experimental Autoimmune Encephalomyelitis
J. Exp. Med., September 6, 1999; 190(5): 733 - 740.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Kim and R. R. Voskuhl
Decreased IL-12 Production Underlies the Decreased Ability of Male Lymph Node Cells to Induce Experimental Autoimmune Encephalomyelitis
J. Immunol., May 1, 1999; 162(9): 5561 - 5568.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. J. Ruiz, H. Garren, D. L. Hirschberg, A. M. Langer-Gould, M. Levite, M. V. Karpuj, S. Southwood, A. Sette, P. Conlon, and L. Steinman
Microbial Epitopes Act as Altered Peptide Ligands to Prevent Experimental Autoimmune Encephalomyelitis
J. Exp. Med., April 19, 1999; 189(8): 1275 - 1284.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. K. Tarrant, P. B. Silver, J. L. Wahlsten, L. V. Rizzo, C.-C. Chan, B. Wiggert, and R. R. Caspi
Interleukin 12 Protects from a T Helper Type 1-mediated Autoimmune Disease, Experimental Autoimmune Uveitis, through a Mechanism Involving Interferon gamma , Nitric Oxide, and Apoptosis
J. Exp. Med., January 18, 1999; 189(2): 219 - 230.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Kumar and E. Sercarz
Induction or Protection from Experimental Autoimmune Encephalomyelitis Depends on the Cytokine Secretion Profile of TCR Peptide-Specific Regulatory CD4 T Cells
J. Immunol., December 15, 1998; 161(12): 6585 - 6591.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. J. Bright, C. Du, M. Coon, S. Sriram, and S. J. Klaus
Prevention of Experimental Allergic Encephalomyelitis via Inhibition of IL-12 Signaling and IL-12-Mediated Th1 Differentiation: An Effect of the Novel Anti-Inflammatory Drug Lisofylline
J. Immunol., December 15, 1998; 161(12): 7015 - 7022.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Drakesmith, D. O'Neil, S. C. Schneider, M. Binks, P. Medd, E. Sercarz, P. Beverley, and B. Chain
In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen
PNAS, December 8, 1998; 95(25): 14903 - 14908.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Wildbaum, S. Youssef, N. Grabie, and N. Karin
Neutralizing Antibodies to IFN-{gamma}-Inducing Factor Prevent Experimental Autoimmune Encephalomyelitis
J. Immunol., December 1, 1998; 161(11): 6368 - 6374.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Offner, K. Adlard, B. F. Bebo Jr., J. Schuster, G. G. Burrows, A. C. Buenafe, and A. A. Vandenbark
Vaccination with BV8S2 Protein Amplifies TCR-Specific Regulation and Protection Against Experimental Autoimmune Encephalomyelitis in TCR BV8S2 Transgenic Mice
J. Immunol., September 1, 1998; 161(5): 2178 - 2186.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Tang, G. C. Sharp, K. P. Peterson, and H. Braley-Mullen
IFN-{gamma}-Deficient Mice Develop Severe Granulomatous Experimental Autoimmune Thyroiditis with Eosinophil Infiltration in Thyroids
J. Immunol., May 15, 1998; 160(10): 5105 - 5112.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
B. M. Segal, B. K. Dwyer, and E. M. Shevach
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
J. Exp. Med., February 16, 1998; 187(4): 537 - 546.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
J. J. Lafaille, F. V. d. Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa
Myelin Basic Protein-specific T Helper 2 (Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect Them from the Disease
J. Exp. Med., July 21, 1997; 186(2): 307 - 312.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.